diet drug "belviq" will hit the u.s. market tuesday, nearly a year after getting approval from the fda. the u.s. drug agency delayed the release on concerns it needs to be listed as a controlled substance because of a low potential for abuse. at the time, belveeq, made by arena, was the first new drug approved by the fda for long-term weightloss in more than a decade. since then, vivus has placed diet drug qsymia on the market. both stocks initially popped on news of the diet drug's approval; however, since then, shares of vivius and arena have been stuck in a trading range. in our cover story, there's a lot buzzing around the specialty coffee industry, which includes coffee roasters, coffee houses and the supply chain that gets it all there. for one thing, it's growing - and according to the specialty coffee association of america, comprises nearly half of all coffee sales in the u.s. the u.s. coffee market is an estimated $30- to $32-billion- a-year industry. cups filled with specialty brews make up 37% of the volume o